Synergetics USA, Inc. (NASDAQ: SURG) reported Q3 EPS of $0.04, in-line with the analyst estimate of $0.04. Revenue for the quarter came in at $16.1 million versus the consensus estimate of $16.5 million.

For earnings history and earnings-related data on Synergetics USA, Inc. (SURG) click here.